Acta Univ. Palacki. Olomuc., Fac. Med. Volume 144, 2000 | DOI: 10.5507/bp.2000.019

EFFECT OF SILYMARIN AND SILIBININ-PHOSPHATIDYLCHOLINE COMPLEX ON PLASMA AND LIPOPROTEIN CHOLESTEROL, AND OXIDATION OF LDL IN RATS FED ON HIGH CHOLESTEROL DIET SUPPLEMENTED WITH CURRANT OIL

Nina Škottováa, Vladimír Krečmanb, Petr Váňaa, Zdeněk Chmelac, Jitka Ulrichováb, Vilím Šimánekb
a Institute of Pharmacology, Medical Faculty, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic
b Institute of Medical Chemistry, Medical Faculty, Palacký University,Hněvotínská 3, 775 15 Olomouc, Czech Republic
c Institute of Pathological Physiology, Medical Faculty, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic

This work was aimed to investigate the currant oil-induced modulation of antihypercholesterolemic and LDLantioxidant effects of silymarin (SM), the extract from Silybum marianum L. containing silibinin as the mainflavonolignan, and of better bioavailable silibinin-phosphatidylcholine complex (SPC) in rats fed on high-cholesterol(HC) high-fat diet. Feeding of rats on HC-diet supplemented with 10 % of currant oil (from Ribes nigrum L.)containing polyunsaturated fatty acids (PUFA, 61.1% of n–6 and 15.4 % of n–3) and lower amounts of saturated(SFA, 7.7%) and monounsaturated (MUFA, 14.3%) fatty acids caused a significant decrease in plasma cholesterolassociated with a mild decrease in VLDL-C and an increase in HDL-C, when compared to rats fed on HC-diet with10 % of lard fat containing low amounts of PUFA (7.7% of n–6 and 0.7 % of n–3) and higher amounts of SFA(42.7%) and MUFA (47.5%). However, currant oil feeding led to the increased oxidizability of LDL. Silymarin, butnot SPC, was effective in prevention of development of dietary induced hypercholesterolemia in the both dietaryfats with slightly better result in diet containing the currant oil. On the other hand, SPC supressed more effectivelythan silymarin LDL oxidizability. The results suggest that antihypercholesterolemic effect of SM in rats fed on HCdietis improved by dietary currant oil, but the currant oil induces an increased oxidizability of LDL. This can besupressed by improvement of bioavailability of silibinin, as shown here for silibinin-phosphatidylcholine complex.

Keywords: Silymarin, Silibinin, Polyunsaturated fatty acids, Lipoprotein cholesterol, LDL oxidation

Published: December 1, 2000  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Škottová, N., Krečman, V., Váňa, P., Chmela, Z., Ulrichová, J., & Šimánek, V. (2000). EFFECT OF SILYMARIN AND SILIBININ-PHOSPHATIDYLCHOLINE COMPLEX ON PLASMA AND LIPOPROTEIN CHOLESTEROL, AND OXIDATION OF LDL IN RATS FED ON HIGH CHOLESTEROL DIET SUPPLEMENTED WITH CURRANT OIL. Biomedical papers, 144(144), 55-58. doi: 10.5507/bp.2000.019
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Grundy, S. M. (1998) Nutrient composition and the metabolic syndrome. In: Atherosclerosis XI. (Eds. Jacotot B., Mathé D. and Fruchart J. C.) , 519-527, Elsevier Science Pte Ltd., Singapore.
    2. Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., Despres, J. P. (1996) Small, dense low-density lipoprotein phenotype as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 94, 69-75. Go to original source...
    3. Steinberg, D., Pathasarathy, S., Carew, T. E., Khoo, J. C., Witztum, J. L. (1989) Modifications of low-density lipoprotein that increase atherogenicity. N. Engl. J. Med. 320, 915-924. Go to original source...
    4. Witztum, J. L. (1994) The oxidation hypothesis of atherosclerosis. Lancet 344, 793-795. DOI: 10.1016/S0140-6736(94)92346-9 Go to original source... Go to PubMed...
    5. Aviram, M. (1996) Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 34, 599-608.
    6. Carmena, R., Ordovas, J. M., Ascaso, J. F., Camejo, G., Hurt- Camejo, E., Martinez-Valls, J. (1998) Dietary composition and low-density lipoprotein (LDL) modifications. In: Atherosclerosis XI. (Eds. Jacotot B., Mathé D. and Fruchart J. C.), 507-517, Elsevier Science Pte Ltd., Singapore.
    7. Lairon, D., Amiot, M. J. (1999) Flavonoids in food and natural antioxidants in wine. Curr. Opin. Lipidol. 10, 23-28. DOI: 10.1097/00041433-199902000-00005 Go to original source... Go to PubMed...
    8. Hertog, M. G. L., Feskens, E. J. M., Hollman, P. C. H., Katan, M. B., Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342, 1007-1011. DOI: 10.1016/0140-6736(93)92876-U Go to original source... Go to PubMed...
    9. Keli, S. O., Hertog, M. G. L., Feskens, E. J. M., Kromhout, D. (1996) Dietary flavonoids, antioxidant vitamins, and incidince of stroke: the Zutphen study. Arch. Intern. Med. 156, 637-642. Go to original source... Go to PubMed...
    10. Knekt, P., Jarvinen, R., Reunanen, A., Maatela, J. (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312, 478-481. Go to original source... Go to PubMed...
    11. Valenzuela, A., Garrido, A. (1994) Biochemical bases of the pharmacological action of the flavonoid silymarin and its structural isomer silibinin. Biol. Res. 27, 105-112.
    12. Krečman, V., Škottová, N., Walterová, D., Ulrichová, J., Šimánek, V. (1998) Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta Med. 64, 138-142. DOI: 10.1055/s-2006-957391 Go to original source... Go to PubMed...
    13. Škottová, N., Krečman, V., Šimánek, V. (1999) Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Phytother. Res. 13, 535-537. Go to original source... Go to PubMed...
    14. Morazzoni, P., Montalbetti, A., Malandrino, S., Pifferi, G. (1993) Comparative pharmacokinetics of silipide and silymarin in rats. Eur. J. Drug Metab. Pharmacokinet. 18, 289-297. Go to original source... Go to PubMed...
    15. Havel, R. J., Eder, H. A., Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353. DOI: 10.1172/JCI103182 Go to original source... Go to PubMed...
    16. Fernandes, A. C., Filipe, P. M., Freitas, J. P., Manso, C. F. (1996) Different effects of thiol and nonthiol ACE inhibitors on copperinduced lipid and protein oxidative modification. Free Radic. Biol. Med. 20, 507-514. Go to original source... Go to PubMed...
    17. Shen-Nan-Lin, Horning, E.C. (1975) Analysis of long-chain acids of human plasma phosphatidylcholines (lecithins) and cholesteryl esters by glass open tubular capillary column gas chromatography for stroke patients and for normal subjects. J. Chrom. 112, 483-497. Go to original source...
    18. Večeřa, R., Chmela, Z., Hřebíček, J., Škottová, N. (1994) Unsaturated fatty acids incorporated in HDL in hypo- and hyperalphalipoproteinemia - relation to the HDL-cholesterol level. Acta Univ. Palacki. Olomuc. 137, 35-38.
    19. Aviram, M. (1998) Macrophages, LDL oxidation and atherosclerosis. In: Atherosclerosis XI. (Eds. Jacotot B., Mathé D. and Fruchart J.C.) , 507-517, Elsevier Science Pte Ltd., Singapore.
    20. Frémont, L., Gozzélino, M. T., Franchi, M. P., Linard, A. (1998) Dietary flavonoids reduce lipid peroxidation in rats fed polyunsaturated or monosaturated fat diets. J. Nutr. 128, 1495-1502. Go to original source... Go to PubMed...
    21. Baroni, S. S., Amelio, M., Sangiorgi, Z., Gaddi, A., Battino, M. (1999) Solid monounsaturated diet lowers LDL unsaturation trait and oxidisability in hypercholesterolemic (type IIb) patients. Free Radic. Res. 30, 275-285. Go to original source... Go to PubMed...

    Return to the content